Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

Omega-3 Polyunsaturated Fatty Acids Time-Dependently Reduce Cell Viability and Oncogenic MicroRNA-21 Expression in Estrogen Receptor-Positive Breast Cancer Cells (MCF-7).

LeMay-Nedjelski L, Mason-Ennis JK, Taibi A, Comelli EM, Thompson LU.

Int J Mol Sci. 2018 Jan 14;19(1). pii: E244. doi: 10.3390/ijms19010244.

2.
3.

α-Linolenic Acid Reduces Growth of Both Triple Negative and Luminal Breast Cancer Cells in High and Low Estrogen Environments.

Wiggins AK, Kharotia S, Mason JK, Thompson LU.

Nutr Cancer. 2015;67(6):1001-9. doi: 10.1080/01635581.2015.1053496. Epub 2015 Jul 2.

PMID:
26134471
4.

Growth and gene expression differ over time in alpha-linolenic acid treated breast cancer cells.

Wiggins AK, Mason JK, Thompson LU.

Exp Cell Res. 2015 Apr 10;333(1):147-54. doi: 10.1016/j.yexcr.2015.02.020. Epub 2015 Mar 2.

PMID:
25743093
5.

Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474).

Mason JK, Fu M, Chen J, Thompson LU.

J Nutr Biochem. 2015 Jan;26(1):16-23. doi: 10.1016/j.jnutbio.2014.08.001. Epub 2014 Sep 22.

PMID:
25441844
6.

17β-estradiol increases liver and serum docosahexaenoic acid in mice fed varying levels of α-linolenic acid.

Mason JK, Kharotia S, Wiggins AK, Kitson AP, Chen J, Bazinet RP, Thompson LU.

Lipids. 2014 Aug;49(8):745-56. doi: 10.1007/s11745-014-3913-8. Epub 2014 Jun 10.

PMID:
24913495
7.

Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer?

Mason JK, Thompson LU.

Appl Physiol Nutr Metab. 2014 Jun;39(6):663-78. doi: 10.1139/apnm-2013-0420. Epub 2013 Dec 23. Review.

PMID:
24869971
8.

Flaxseed enhances the beneficial effect of low-dose estrogen therapy at reducing bone turnover and preserving bone microarchitecture in ovariectomized rats.

Sacco SM, Chen J, Ganss B, Thompson LU, Ward WE.

Appl Physiol Nutr Metab. 2014 Jul;39(7):801-10. doi: 10.1139/apnm-2013-0417. Epub 2014 Jan 16.

PMID:
24844286
9.

A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers.

McCann SE, Edge SB, Hicks DG, Thompson LU, Morrison CD, Fetterly G, Andrews C, Clark K, Wilton J, Kulkarni S.

Nutr Cancer. 2014;66(4):566-75. doi: 10.1080/01635581.2014.894097. Epub 2014 Mar 26.

10.

Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474).

Mason JK, Fu MH, Chen J, Yu Z, Thompson LU.

Nutr Cancer. 2013;65(3):451-9. doi: 10.1080/01635581.2013.756921.

PMID:
23530645
11.

Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk.

Boucher BA, Cotterchio M, Anderson LN, Kreiger N, Kirsh VA, Thompson LU.

Int J Cancer. 2013 Mar 15;132(6):1439-50. doi: 10.1002/ijc.27769. Epub 2012 Sep 18.

12.

Flaxseed does not enhance the estrogenic effect of low-dose estrogen therapy on markers of uterine health in ovariectomized rats.

Sacco SM, Jiang JM, Thompson LU, Ward WE.

J Med Food. 2012 Sep;15(9):846-50. doi: 10.1089/jmf.2011.0314. Epub 2012 Aug 2.

PMID:
22856466
13.

Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice.

Truan JS, Chen JM, Thompson LU.

Nutr Cancer. 2012;64(1):65-71. doi: 10.1080/01635581.2012.630165. Epub 2011 Dec 2.

PMID:
22136581
14.

Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics.

McCann SE, Hootman KC, Weaver AM, Thompson LU, Morrison C, Hwang H, Edge SB, Ambrosone CB, Horvath PJ, Kulkarni SA.

J Nutr. 2012 Jan;142(1):91-8. doi: 10.3945/jn.111.147264. Epub 2011 Nov 23.

15.

Accessibility of ³H-secoisolariciresinol diglycoside lignan metabolites in skeletal tissue of ovariectomized rats.

Sacco SM, Thompson LU, Ganss B, Ward WE.

J Med Food. 2011 Oct;14(10):1208-14. doi: 10.1089/jmf.2010.0248. Epub 2011 Jun 11.

PMID:
21663478
16.

Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.

Chen J, Saggar JK, Ward WE, Thompson LU.

J Toxicol Environ Health A. 2011;74(12):757-68. doi: 10.1080/15287394.2011.567950.

PMID:
21541878
17.

Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.

Chen J, Saggar JK, Corey P, Thompson LU.

Br J Nutr. 2011 Feb;105(3):339-47. doi: 10.1017/S0007114510003557. Epub 2010 Dec 7.

PMID:
21138602
18.

Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring.

Ly A, Lee H, Chen J, Sie KK, Renlund R, Medline A, Sohn KJ, Croxford R, Thompson LU, Kim YI.

Cancer Res. 2011 Feb 1;71(3):988-97. doi: 10.1158/0008-5472.CAN-10-2379. Epub 2010 Dec 6.

19.

Flaxseed oil-trastuzumab interaction in breast cancer.

Mason JK, Chen J, Thompson LU.

Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2223-6. doi: 10.1016/j.fct.2010.05.052. Epub 2010 May 24.

PMID:
20580760
20.

The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways.

Saggar JK, Chen J, Corey P, Thompson LU.

Nutr Cancer. 2010;62(4):533-42. doi: 10.1080/01635580903532440.

PMID:
20432175

Supplemental Content

Loading ...
Support Center